Yorktown Management & Research Company’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,782
Closed -$258K 205
2022
Q2
$258K Hold
5,782
0.33% 133
2022
Q1
$327K Hold
5,782
0.28% 143
2021
Q4
$300K Hold
5,782
0.2% 187
2021
Q3
$345K Hold
5,782
0.26% 159
2021
Q2
$359K Hold
5,782
0.28% 150
2021
Q1
$377K Hold
5,782
0.31% 114
2020
Q4
$380K Hold
5,782
0.34% 145
2020
Q3
$299K Hold
5,782
0.28% 194
2020
Q2
$285K Sell
5,782
-15,336
-73% -$828K 0.26% 207
2020
Q1
$1.08M Buy
21,118
+17,347
+460% +$1M 1.09% 3
2019
Q4
$208K Buy
+3,771
New +$205K 0.11% 271

Other funds holding EHC

Yorktown Management & Research Company's EHC Position: Q3 2022 in Review

Yorktown Management & Research Company sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 5,782 shares — an estimated $258K sold.

Yorktown Management & Research Company first reported a position in EHC in Q4 2019 and held it in 11 quarters. The position peaked at $1.08M in Q1 2020. 347 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Yorktown Management & Research Company reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 5,782 Encompass Health shares in Q3 2022, an estimated $258K.
  • Yorktown Management & Research Company first reported a position in Encompass Health in Q4 2019 and held it in 11 quarters.
  • Yorktown Management & Research Company's Encompass Health position peaked at $1.08M in Q1 2020.
  • 347 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Yorktown Management & Research Company's 13F filing for Q3 2022, filed 4 Nov 2022.